Karyopharm Therapeutics (KPTI) Stock Price
$5.41 5.6%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
3
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Karyopharm Therapeutics, AI stock picks, stock alerts and much more.
KPTI AI Stock Analysis
AI stock analysis for KPTI is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Karyopharm Therapeutics (KPTI) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Karyopharm Therapeutics (KPTI) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Karyopharm Therapeutics (KPTI), currently trading at $5.41, will... Sign up to access price prediction.
About KPTI
-
Karyopharm Therapeutics Inc.
-
Symbol
KPTI
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
46.9M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.78 3% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.3 0.4% |
2 |
 |
Moderna MRNA |
$25.24 0.8% |
4 |
 |
Anavex Life Sciences AVXL |
$8.46 2.4% |
5 |
 |
BridgeBio Pharma BBIO |
$52.37 1.8% |
6 |
News
KPTI Alternative Data
Web Traffic
Karyopharm Therapeutics receives an estimated 10904 monthly visitors to karyopharm.com.
-
Web Traffic
10904
-
Change from Previous Month
8.6%
-
3 Month Change
75.5%
-
YoY Change
75.5%
Twitter Followers
Karyopharm Therapeutics has 1,562 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
1562
-
Daily Change
0.1%
-
1 Month Change
0.3%
-
3 Month Change
0.8%
-
YoY Change
0.8%
LinkedIn Followers
35,448 are following Karyopharm Therapeutics on LinkedIn, up by 0.4% over the last month.
-
LinkedIn Followers
35448
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
1.5%
-
YoY Change
1.5%
Job Postings
Karyopharm Therapeutics currenly has an estimated 7 open job postings, up by 16.7% over the last month.
-
Job Postings
7
-
Daily Change
0%
-
1 Month Change
16.7%
-
3 Month Change
16.7%
-
YoY Change
16.7%
LinkedIn Employees
According to LinkedIn, Karyopharm Therapeutics has 326 employees, down by -4.4% over the last month.
-
LinkedIn Employees
326
-
Daily Change
0.6%
-
1 Month Change
4.4%
-
3 Month Change
9.2%
-
YoY Change
9.2%
Reddit Mentions
Karyopharm Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Karyopharm Therapeutics is 70 out of 100 (bullish).
-
Business Outlook
70
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Karyopharm Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Facebook Engagement
Karyopharm Therapeutics has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
KPTI Financials
KPTI Key Metrics
-
Total Revenue
$30.5M
-
Net Income
-$30.8M
-
Earnings per Share
$0.0924
-
Free cash flow
-$25.8M
-
EBITDA
-$19.6M
-
EBITDA Ratio
-0.64187
-
Total Assets
$164.4M
KPTI 2-year Revenue & Income
KPTI 2-year Free Cash Flow
KPTI Technicals
KPTI SMA
KPTI RSI
FAQ
What's the current price of Karyopharm Therapeutics (KPTI) Stock?
The price of an Karyopharm Therapeutics (KPTI) share is $5.41.
What's the market cap of Karyopharm Therapeutics?
The current market cap of Karyopharm Therapeutics is 46.9M.
What are some stocks similar to Karyopharm Therapeutics (KPTI) that investors often compare it to?
Karyopharm Therapeutics (KPTI) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Karyopharm Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Karyopharm Therapeutics' stock price to be around $5.23 in 2026. Starting from the current price of $5.41, this represents a 3.4% change in price, indicating a neutral outlook for the stock.
How to buy Karyopharm Therapeutics (KPTI) Stock?
Karyopharm Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Karyopharm Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.